Cargando…
Less cholesterol means better tumor killing for cytotoxic T9 cells
In this issue, Ma et al. (https://doi.org/10.1084/jem.20171576) show that removal of cholesterol from CD8 T cells during type 9 differentiation increases their IL-9 production, persistence in vivo, and cytolytic function against tumors by preventing SUMOylation of liver X receptors.
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987929/ https://www.ncbi.nlm.nih.gov/pubmed/29764914 http://dx.doi.org/10.1084/jem.20180852 |
_version_ | 1783329210834616320 |
---|---|
author | Griesenauer, Brad Paczesny, Sophie |
author_facet | Griesenauer, Brad Paczesny, Sophie |
author_sort | Griesenauer, Brad |
collection | PubMed |
description | In this issue, Ma et al. (https://doi.org/10.1084/jem.20171576) show that removal of cholesterol from CD8 T cells during type 9 differentiation increases their IL-9 production, persistence in vivo, and cytolytic function against tumors by preventing SUMOylation of liver X receptors. |
format | Online Article Text |
id | pubmed-5987929 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-59879292018-12-04 Less cholesterol means better tumor killing for cytotoxic T9 cells Griesenauer, Brad Paczesny, Sophie J Exp Med News In this issue, Ma et al. (https://doi.org/10.1084/jem.20171576) show that removal of cholesterol from CD8 T cells during type 9 differentiation increases their IL-9 production, persistence in vivo, and cytolytic function against tumors by preventing SUMOylation of liver X receptors. Rockefeller University Press 2018-06-04 /pmc/articles/PMC5987929/ /pubmed/29764914 http://dx.doi.org/10.1084/jem.20180852 Text en © 2018 Griesenauer and Paczesny http://www.rupress.org/terms/https://creativecommons.org/licenses/by-nc-sa/4.0/This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms/). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 International license, as described at https://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | News Griesenauer, Brad Paczesny, Sophie Less cholesterol means better tumor killing for cytotoxic T9 cells |
title | Less cholesterol means better tumor killing for cytotoxic T9 cells |
title_full | Less cholesterol means better tumor killing for cytotoxic T9 cells |
title_fullStr | Less cholesterol means better tumor killing for cytotoxic T9 cells |
title_full_unstemmed | Less cholesterol means better tumor killing for cytotoxic T9 cells |
title_short | Less cholesterol means better tumor killing for cytotoxic T9 cells |
title_sort | less cholesterol means better tumor killing for cytotoxic t9 cells |
topic | News |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5987929/ https://www.ncbi.nlm.nih.gov/pubmed/29764914 http://dx.doi.org/10.1084/jem.20180852 |
work_keys_str_mv | AT griesenauerbrad lesscholesterolmeansbettertumorkillingforcytotoxict9cells AT paczesnysophie lesscholesterolmeansbettertumorkillingforcytotoxict9cells |